Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2025 10:33 ET | Source: Research and Markets

Cervical Dystonia Research Analysis Report 2025-2035: Market Sees Intense Competition as Ipsen, Merz, and AbbVie Advance Therapies Through Strategic Expansions

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Cervical Dystonia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
November 13, 2025 12:47 ET | Source: Kelyniam Global Inc.

Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants

Kelyniam received a exclusive U.S. license from Evonik to market VESTAKEEP® Fusion, a bi-calcium phosphate-infused PEEK material, for cranial implants
November 12, 2025 08:00 ET | Source: NeurAxis, Inc.

NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives

CARMEL, Ind., Nov. 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
November 11, 2025 09:00 ET | Source: Gnome Sciences

Gnome Sciences Announces Cancer Drug Shows Promise in Stopping Progression of ALS

Gnome Sciences Discovers Cancer Drug Shows Promise in Stopping Progression of ALS. BCL2 inhibitors such as venetoclax may treat neurodegenerative diseases
November 10, 2025 07:25 ET | Source: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System

– Data highlights symptom stability and enhanced efficacy signals in higher dose group – – Analysis offers valuable insights to guide ongoing development and planning of Phase 3 – MELBOURNE,...
November 06, 2025 04:07 ET | Source: Research and Markets

Germany Neurology KOLs Fair-Market Value Compensation Rates Report 2025: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs)

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Germany Fair-Market Value Compensation Rates for Neurology KOLs" report has been added to ResearchAndMarkets.com's offering.This report presents...
November 05, 2025 12:16 ET | Source: Medical Microinstruments, Inc.

UPDATE - MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients

JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for...
November 04, 2025 11:22 ET | Source: Research and Markets

AI-Powered Acute Stroke Triage Research Report 2025: Market to Reach $3.83 Billion by 2029 at a CAGR of 22.2%, Amid Push for Faster, Smarter Emergency Care - Global Long-term Forecast to 2034

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The artificial...
October 31, 2025 07:25 ET | Source: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report

Highlights New analysis of ATH434-201 double blind trial strengthens efficacy signal at high dose levelPositive data from ATH434-202 open-label trial demonstrates similar treatment effect in advanced...
October 27, 2025 08:00 ET | Source: Halberd Corp.

Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform

Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform